Decision Support
Compare Products
Side-by-side comparison of 2–3 reviewed products. Empty cells mean the manufacturer has not published that value — we show what sources support, nothing more.
Filled with competing tests for the same target from other manufacturers, where the catalogue has them — swap any column with the picker above.
| Field | Allplex™ Vaginitis Screening Assay | VitaSIRO solo™ CT/NG/TV/MG Assay | Chlamydia trachomatis and Ureaplasma urealyticum nucleic acid detection kit |
|---|---|---|---|
| Manufacturer | Seegene | Credo Diagnostics | BGI Genomics Co., Ltd. |
| Country | Not disclosed | Singapore | China |
| Category | Automation | Molecular Assays / STI Tests | Molecular Assays / STI Tests |
| Technology | qPCR | POCT Molecular | qPCR |
| Assay format | Not disclosed | Singleplex | Not disclosed |
| System type | Not disclosed | Open system | Not disclosed |
| Sample types | Not disclosed | Urine, Cervical Sample | Not disclosed |
| Targets | Atopobium vaginae (Quantitative), Candida albicans, Candida others, Gardnerella vaginalis (Quantitative), Lactobacillus spp. (Quantitative) (Lacto), Mobiluncus spp., Trichomonas vaginalis | Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium | Not disclosed |
| Turnaround | Not disclosed | 45 min | Not disclosed |
| Reactions per kit | Not disclosed | 12 | Not disclosed |
| Regulatory status | Not disclosed | RUO | CE-IVD |
| Verified | 2026-10-16 | 2026-10-03 | 2026-10-04 |
| Linked registration records | 0 record(s) | 0 record(s) | 0 record(s) |
| Source | Official page | Official page | Official page |
| Next step | Request quote | Request quote | Request quote |
Comparisons use manufacturer-published specifications and our editorial review; registration claims are counted from linked regulatory records only.